Home › Compare › CWBR vs O

CWBR vs O: Dividend Comparison 2026

CWBR yields 487.80% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CWBR wins by $50753.86M in total portfolio value
10 years
CWBR
CWBR
● Live price
487.80%
Share price
$0.41
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$50753.89M
Annual income
$36,168,404,531.85
Full CWBR calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.18
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,098.20
Full O calculator →

Portfolio growth — CWBR vs O

📍 CWBR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCWBRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CWBR + O cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CWBR pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CWBR
Annual income on $10K today (after 15% tax)
$41,463.41/yr
After 10yr DRIP, annual income (after tax)
$30,743,143,852.07/yr
O
Annual income on $10K today (after 15% tax)
$448.90/yr
After 10yr DRIP, annual income (after tax)
$4,333.47/yr
At 15% tax rate, CWBR beats the other by $30,743,139,518.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CWBR + O for your $10,000?

CWBR: 50%O: 50%
100% O50/50100% CWBR
Portfolio after 10yr
$25376.96M
Annual income
$18,084,204,815.03/yr
Blended yield
71.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

CWBR
Analyst Ratings
5
Buy
Consensus: Buy
Altman Z
-13.8
Piotroski
1/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.6% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CWBR buys
0
O buys
0
No recent congressional trades found for CWBR or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCWBRO
Forward yield487.80% ✓5.28%
Annual dividend / share$2.00$3.23 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1% ✓
Portfolio after 10y$50753.89M ✓$34.2K
Annual income after 10y$36,168,404,531.85 ✓$5,098.20
Total dividends collected$49478.61M ✓$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: CWBR vs O ($10,000, DRIP)

YearCWBR PortfolioCWBR Income/yrO PortfolioO Income/yrGap
1← crossover$59,480$48,780.49$10,818$607.86+$48.7K → CWBR
2$334,811$271,167.03$11,786$741.30+$323.0K → CWBR
3$1,784,770$1,426,522.08$12,944$910.50+$1.77M → CWBR
4$9,016,553$7,106,848.63$14,343$1,127.28+$9.00M → CWBR
5$43,202,271$33,554,559.81$16,053$1,408.17+$43.19M → CWBR
6$196,483,123$150,256,693.49$18,167$1,776.65+$196.46M → CWBR
7$848,895,486$638,658,543.63$20,815$2,266.60+$848.87M → CWBR
8$3,487,095,949$2,578,777,778.75$24,179$2,927.66+$3487.07M → CWBR
9$13,631,297,985$9,900,105,319.66$28,521$3,833.95+$13631.27M → CWBR
10$50,753,893,375$36,168,404,531.85$34,218$5,098.20+$50753.86M → CWBR

CWBR vs O: Complete Analysis 2026

CWBR — Stock

CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.

Full CWBR Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this CWBR vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CWBR vs SCHDCWBR vs JEPICWBR vs KOCWBR vs MAINCWBR vs STAGCWBR vs ADCCWBR vs NNNCWBR vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.